Drug Type Antibody oligonucleotide conjugates |
Synonyms AOC 1072, AOC1072 |
Target |
Mechanism PRKAG2 modulators(protein kinase AMP-activated non-catalytic subunit gamma 2 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Cardiomyopathies | Preclinical | US | 01 Dec 2024 |